Emapalumab
Emapalumab (NI-0501) is a human monoclonal IgG1 antibody that noncompetitively inhibits IFN-γ. Emapalumab binds with high affinity (Kd= 1.4 pM) to both free IFN-γ as well as IFN-γ bound to its receptor. Emapalumab can be used in research of hemophagocytic lymphohistiocytosis (HLH) [1].
Product Specifications
CAS Number
1709815-23-5
Product Name Alternative
NI-0501
UNSPSC
12352203
Target
IFNAR
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/emapalumab.html
Purity
98.86
Solubility
10 mM in DMSO
Smiles
[Emapalumab]
Molecular Weight
(145.22 kDa)
References & Citations
[1]Vallurupalli M, et, al. Emapalumab for the treatment of relapsed/refractory hemophagocytic lymphohistiocytosis. Blood. 2019 Nov 21;134 (21) :1783-1786.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
43291121 3x 1.0µg DNA
SEC14L6 CRISPRa sgRNA lentivector (set of three targets)(Human)
Sign In for Pricing
View Details 
orb2853732 100 µL
Phospho-Histone H1oo (Ser20) Rabbit pAb, PE-Cy5.5 conjugated
Sign In for Pricing
View Details CF500502 100 µg
STK39 Mouse Monoclonal Antibody [Clone ID: OTI3C12]
Sign In for Pricing
View Details 
38945156 3x 1.0 µg DNA
RGD1305627 CRISPR All-in-one AAV vector set (with saCas9)(Rat)
Sign In for Pricing
View Details NT16652-01 50 mg
2',3',5'-Tris-O-[tert-butyldimethylsilyl]-2-chloroadenosine
Sign In for Pricing
View Details